These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 552898)

  • 61. [INFLUENCE OF ANGIOPROTECTOR DRUGS ON THE EFFICACY OF CYTOSTATIC THERAPY (EXPERIMENTAL STUDY)].
    Trashkov AP; Vasil'ev AG; Kovalenko AL; Petrov AY; Valeev VV
    Eksp Klin Farmakol; 2016; 79(2):34-9. PubMed ID: 27416681
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Study of antitumor activity of antibodies to TNF-α on Walker carcinosarcoma model.
    Yurlova EI; Krylova SG; Dugina JL; Epstein OI
    Bull Exp Biol Med; 2013 Sep; 155(5):673-5. PubMed ID: 24288736
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of Walker 256 intramuscular carcinoma in rats by administration of hydrazine sulfate.
    Gold J
    Oncology; 1971; 25(1):66-71. PubMed ID: 5090420
    [No Abstract]   [Full Text] [Related]  

  • 64. Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma.
    DeWys WD; Humphreys SR; Goldin A
    Cancer Chemother Rep; 1968 Feb; 52(2):229-42. PubMed ID: 5646850
    [No Abstract]   [Full Text] [Related]  

  • 65. The effect of in situ isolated perfusion of experimental renal tumors with cytotoxic agents in high concentration.
    Asbach HW; Bersch W
    Urol Int; 1980; 35(2):112-24. PubMed ID: 7376296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.
    Volm M; Mattern J; Weber N; Wayss K
    Cancer Chemother Pharmacol; 1980; 4(2):89-93. PubMed ID: 6156026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Tumor hyperacidulation through glucose infusion enhanced by nicotinamide adenine dinucleotide (author's transl)].
    von Ardenne M; Reitnauer PG
    Arch Geschwulstforsch; 1976; 46(3):197-203. PubMed ID: 184752
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
    Dolowy WC; Schrek R; Henson D; Cornet J; Brown E
    Nature; 1968 Jun; 218(5146):1028-31. PubMed ID: 5656616
    [No Abstract]   [Full Text] [Related]  

  • 69. Antitumor activity of a polychlorinated biphenyl mixture, Aroclor 1254, in rats inoculated with Walker 256 carcinosarcoma cells.
    Kerkvliet NI; Kimeldorf DJ
    J Natl Cancer Inst; 1977 Sep; 59(3):951-5. PubMed ID: 408506
    [No Abstract]   [Full Text] [Related]  

  • 70. Alteration of tumor growth by a purified alpha-2-glycoprotein.
    Saba TM; Cho E
    J Reticuloendothel Soc; 1977 Dec; 22(6):583-96. PubMed ID: 73587
    [No Abstract]   [Full Text] [Related]  

  • 71. Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) [KTS; NSC-82116] against murine tumors.
    Petering HG; Buskirk HH; Crim JA
    Cancer Chemother Rep; 1966 Nov; 50(8):557-64. PubMed ID: 5978728
    [No Abstract]   [Full Text] [Related]  

  • 72. Synthesis, antitumor activity, distribution and toxicity of 4-[4-[bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma.
    Wingen F; Sterz H; Blum H; Möller H; Pittermann W; Pool BL; Sinn HJ; Spring H; Schmähl D
    J Cancer Res Clin Oncol; 1986; 111(3):209-19. PubMed ID: 3525574
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aprotinin and growth of Walker 256 carcinosarcoma in the rat.
    Thomson AW; Pugh-Humphreys RG; Horne CH; Tweedle DJ
    Br J Cancer; 1977 Apr; 35(4):454-60. PubMed ID: 300627
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Results of local sclerosing therapy in the treatment of Walker 256 carcinosarcoma implanted in the liver].
    De Macedo AR; Faifer JG; Hossne WS
    Chir Patol Sper; 1979 Oct; 27(5):444-55. PubMed ID: 261944
    [No Abstract]   [Full Text] [Related]  

  • 75. Antitumor effect of GPA1734 in rat Walker 256 carcinoma.
    Missirlis E; Karakiulakis G; Maragoudakis ME
    Invest New Drugs; 1990 May; 8(2):145-7. PubMed ID: 2384301
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antitumor agents. XV: Deoxyelephantopin, an antitumor principle from Elephantopus carolinianus Willd.
    Lee KH; Cowherd CM; Wolo MT
    J Pharm Sci; 1975 Sep; 64(9):1572-3. PubMed ID: 1185584
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats.
    Harrison EF; Fuquay ME; Hunter HL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):25-8. PubMed ID: 6836324
    [No Abstract]   [Full Text] [Related]  

  • 78. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
    Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
    Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesis.
    Powles TJ; Alexander P; Millar JL
    Biochem Pharmacol; 1978 May; 27(9):1389-92. PubMed ID: 697942
    [No Abstract]   [Full Text] [Related]  

  • 80. Anticoagulant treatment of rats with Walker 256 carcinosarcoma.
    Owen CA
    J Cancer Res Clin Oncol; 1982; 104(1-2):191-3. PubMed ID: 7130245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.